|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buckner JC, Brown PD, O'Neill BP, Meyer
FB, Wetmore CJ and Uhm JH: Central nervous system tumors. Mayo Clin
Proc. 82:pp. 1271–1286. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu X, Wang S, Yuan A, Yuan X and Liu B:
MicroRNA-140 represses glioma growth and metastasis by directly
targeting ADAM9. Oncol Rep. 36:2329–2338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu GY, Shi BZ and Li Y: FoxM1 regulates
Sirt1 expression in glioma cells. Eur Rev Med Pharmacol Sci.
18:205–211. 2014.PubMed/NCBI
|
|
5
|
Chen J, McKay RM and Parada LF: Malignant
glioma: Lessons from genomics, mouse models, and stem cells. Cell.
149:36–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stupp R, Mason WP, Van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lefranc F, Brotchi J and Kiss R: Possible
future issues in the treatment of glioblastomas: Special emphasis
on cell migration and the resistance of migrating glioblastoma
cells to apoptosis. J Clin Oncol. 23:2411–2422. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Onishi M, Ichikawa T, Kurozumi K and Date
I: Angiogenesis and invasion in glioma. Brain Tumor Pathol.
28:13–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carrington JC and Ambros V: Role of
microRNAs in plant and animal development. Science. 301:336–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin B, Yang H and Xiao B: Role of
microRNAs in endothelial inflammation and senescence. Mol Biol Rep.
39:4509–4518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kotaja N: MicroRNAs and spermatogenesis.
Fertil Steril. 101:1552–1562. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Imbar T and Eisenberg I: Regulatory role
of microRNAs in ovarian function. Fertil Steril. 101:1524–1530.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garg D and Cohen SM: miRNAs and aging: A
genetic perspective. Ageing Res Rev. 17:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dogini DB, Pascoal VD, Avansini SH, Vieira
AS, Pereira TC and Lopes-Cendes I: The new world of RNAs. Genet Mol
Biol. 37 1 Suppl:S285–S293. 2014. View Article : Google Scholar
|
|
16
|
Hong L, Ya-Wei L, Hai W, Qiang Z, Jun-Jie
L, Huang A, Song-Tao Q and Yun-Tao L: MiR-519a functions as a tumor
suppressor in glioma by targeting the oncogenic STAT3 pathway. J
Neurooncol. 128:35–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teoh SL and Das S: The role of MicroRNAs
in diagnosis, prognosis, metastasis and resistant cases in breast
cancer. Curr Pharm Des. 23:1845–1859. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu HT, Wang YW, Xing AY, Shi DB, Zhang H,
Guo XY, Xu J and Gao P: Prognostic value of microRNA signature in
patients with gastric cancers. Sci Rep. 7:428062017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong F, Xu T, Shen Y, Zhong S, Chen S,
Ding Q and Shen Z: Dysregulation of miRNAs in bladder cancer:
Altered expression with aberrant biogenesis procedure. Oncotarget.
8:27547–27568. 2017.PubMed/NCBI
|
|
20
|
Liu L, Bi N, Wu L, Ding X, Men Y, Zhou W,
Li L, Zhang W, Shi S, Song Y and Wang L: MicroRNA-29c functions as
a tumor suppressor by targeting VEGFA in lung adenocarcinoma. Mol
Cancer. 16:502017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y, Gao DY and Huang L: In vivo
delivery of miRNAs for cancer therapy: Challenges and strategies.
Adv Drug Deliv Rev. 81:128–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Turner JD, Williamson R, Almefty KK,
Nakaji P, Porter R, Tse V and Kalani MY: The many roles of
microRNAs in brain tumor biology. Neurosurg Focus. 28:E32010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Geng L, Sun B, Gao B, Wang Z, Quan C, Wei
F and Fang XD: MicroRNA-103 promotes colorectal cancer by targeting
tumor suppressor DICER and PTEN. Int J Mol Sci. 15:8458–8472. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu D, Zhou H, Xun Q, Xu X, Ling J and Hu
Y: microRNA-103 regulates the growth and invasion of endometrial
cancer cells through the downregulation of tissue inhibitor of
metalloproteinase 3. Oncol Lett. 3:1221–1226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fu X, Zhang W, Su Y, Lu L, Wang D and Wang
H: MicroRNA-103 suppresses tumor cell proliferation by targeting
PDCD10 in prostate cancer. Prostate. 76:543–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Neviani P and Fabbri M: Exosomic microRNAs
in the tumor microenvironment. Front Med (Lausanne).
2:472015.PubMed/NCBI
|
|
30
|
Zhao Y, Pang D, Wang C, Zhong S and Wang
S: MicroRNA-134 modulates glioma cell U251 proliferation and
invasion by targeting KRAS and suppressing the ERK pathway. Tumour
Biol. 37:11485–11493. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tian LQ, Liu EQ, Zhu XD, Wang XG, Li J and
Xu GM: MicroRNA-197 inhibits cell proliferation by targeting GAB2
in glioblastoma. Mol Med Rep. 13:4279–4288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang J, Liu X, Xue H, Qiu B, Wei B and
Sun K: MicroRNA-103a inhibits gastric cancer cell proliferation,
migration and invasion by targeting c-Myb. Cell Prolif. 48:78–85.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng YB, Xiao K, Xiao GC, Tong SL, Ding
Y, Wang QS, Li SB and Hao ZN: MicroRNA-103 promotes tumor growth
and metastasis in colorectal cancer by directly targeting LATS2.
Oncol Lett. 12:2194–2200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang X, Wu X, Yan L and Shao J: Serum
miR-103 as a potential diagnostic biomarker for breast cancer. Nan
Fang Yi Ke Da Xue Xue Bao. 32:631–634. 2012.(In Chinese).
PubMed/NCBI
|
|
36
|
Xia W, Ni J, Zhuang J, Qian L, Wang P and
Wang J: MiR-103 regulates hepatocellular carcinoma growth by
targeting AKAP12. Int J Biochem Cell Biol. 71:1–11. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi B, Lee EJ, Shin MK, Park YS, Ryu MH,
Kim SM, Kim EY, Lee HK and Chang EJ: Upregulation of brain-derived
neurotrophic factor in advanced gastric cancer contributes to bone
metastatic osteolysis by inducing long pentraxin 3. Oncotarget.
7:55506–55517. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang SY, Hui LP, Li CY, Gao J, Cui ZS and
Qiu XS: More expression of BDNF associates with lung squamous cell
carcinoma and is critical to the proliferation and invasion of lung
cancer cells. BMC Cancer. 16:1712016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Moon A, Won KY, Lee JY, Kang I, Lee SK and
Lee J: Expression of BDNF, TrkB, and p53 in early-stage squamous
cell carcinoma of the uterine cervix. Pathology. 43:453–458. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Patani N, Jiang WG and Mokbel K:
Brain-derived neurotrophic factor expression predicts adverse
pathological & clinical outcomes in human breast cancer. Cancer
Cell Int. 11:232011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang X, Martin TA and Jiang WG: Biological
influence of brain-derived neurotrophic factor (BDNF) on colon
cancer cells. Exp Ther Med. 6:1475–1481. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang ZF, Ho DW, Lam CT, Luk JM, Lum CT, Yu
WC, Poon RT and Fan ST: Identification of brain-derived
neurotrophic factor as a novel functional protein in hepatocellular
carcinoma. Cancer Res. 65:219–225. 2005.PubMed/NCBI
|
|
43
|
Tajbakhsh A, Mokhtari-Zaer A, Rezaee M,
Afzaljavan F, Rivandi M, Hassanian SM, Ferns GA, Pasdar A and Avan
A: Therapeutic potentials of BDNF/TrkB in breast cancer; current
status and perspectives. J Cell Biochem. 118:2502–2515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yan Q, Yu HL and Li JT: Study on the
expression of BDNF in human gliomas. Sichuan Da Xue Xue Bao Yi Xue
Ban. 40:415–417. 2009.(In Chinese). PubMed/NCBI
|
|
45
|
Xiong J, Zhou L, Lim Y, Yang M, Zhu YH, Li
ZW, Zhou FH, Xiao ZC and Zhou XF: Mature BDNF promotes the growth
of glioma cells in vitro. Oncol Rep. 30:2719–2724. 2013. View Article : Google Scholar : PubMed/NCBI
|
